760 related articles for article (PubMed ID: 38008779)
1. Signaling pathways and targeted therapies for psoriasis.
Guo J; Zhang H; Lin W; Lu L; Su J; Chen X
Signal Transduct Target Ther; 2023 Nov; 8(1):437. PubMed ID: 38008779
[TBL] [Abstract][Full Text] [Related]
2. Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities.
Srivastava AK; Chand Yadav T; Khera HK; Mishra P; Raghuwanshi N; Pruthi V; Prasad R
J Autoimmun; 2021 Mar; 118():102614. PubMed ID: 33578119
[TBL] [Abstract][Full Text] [Related]
3. The Inflammatory Response in Psoriasis: a Comprehensive Review.
Deng Y; Chang C; Lu Q
Clin Rev Allergy Immunol; 2016 Jun; 50(3):377-89. PubMed ID: 27025861
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.
Woo YR; Cho DH; Park HJ
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232931
[TBL] [Abstract][Full Text] [Related]
5. Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets.
Li L; Lu J; Liu J; Wu J; Zhang X; Meng Y; Wu X; Tai Z; Zhu Q; Chen Z
Front Immunol; 2023; 14():1340677. PubMed ID: 38239345
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis: Recent progress in molecular-targeted therapies.
Honma M; Hayashi K
J Dermatol; 2021 Jun; 48(6):761-777. PubMed ID: 33404109
[TBL] [Abstract][Full Text] [Related]
7. Newer targeted therapies in psoriasis.
Khandpur S; Bhari N
Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S47-52. PubMed ID: 23974694
[TBL] [Abstract][Full Text] [Related]
8. New insights into different adipokines in linking the pathophysiology of obesity and psoriasis.
Kong Y; Zhang S; Wu R; Su X; Peng D; Zhao M; Su Y
Lipids Health Dis; 2019 Sep; 18(1):171. PubMed ID: 31521168
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis Pathogenesis and Treatment.
Rendon A; Schäkel K
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909615
[TBL] [Abstract][Full Text] [Related]
10. Non-immune functions of inflammatory cytokines targeted by anti-psoriatic biologics: a review.
Lee TL; Tsai TF
Inflamm Res; 2022 Feb; 71(2):157-168. PubMed ID: 34981130
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics in the pathogenesis and pathophysiology of psoriasis vulgaris.
Trowbridge RM; Pittelkow MR
J Drugs Dermatol; 2014 Feb; 13(2):111-8. PubMed ID: 24509958
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis.
Griffiths CEM; Armstrong AW; Gudjonsson JE; Barker JNWN
Lancet; 2021 Apr; 397(10281):1301-1315. PubMed ID: 33812489
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine.
Alwan W; Nestle FO
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S2-6. PubMed ID: 26472336
[TBL] [Abstract][Full Text] [Related]
14. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic downregulation of SFRP4 contributes to epidermal hyperplasia in psoriasis.
Bai J; Liu Z; Xu Z; Ke F; Zhang L; Zhu H; Lou F; Wang H; Fei Y; Shi YL; Wang H
J Immunol; 2015 May; 194(9):4185-98. PubMed ID: 25825452
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics of Psoriasis.
Shao S; Gudjonsson JE
Adv Exp Med Biol; 2020; 1253():209-221. PubMed ID: 32445097
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.
Nickoloff BJ; Nestle FO
J Clin Invest; 2004 Jun; 113(12):1664-75. PubMed ID: 15199399
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis: what we have learned from mouse models.
Wagner EF; Schonthaler HB; Guinea-Viniegra J; Tschachler E
Nat Rev Rheumatol; 2010 Dec; 6(12):704-14. PubMed ID: 20877306
[TBL] [Abstract][Full Text] [Related]
19. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
20. The Genetic Susceptibility to Psoriasis and the Relationship of Linked Genes to Our Treatment Options.
Patel HA; Revankar RR; Pedroza ST; Graham S; Feldman SR
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
